Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Knocked Down But Not Out: Recovering From a Refuse to File

Apr 01 2008

• By Ramsey Baghdadi

Related Content

Nothing Random About It: The State of Cancer Drug Development at FDA

Mar 01 2006

Getting the Bugs Out of Antibiotic R&D: Commercial Implications of a Higher Regulatory Hurdle

Jun 01 2007

The New User Fee Rules: FDA Sacrifices Timeliness, Tries to Save Predictability

Mar 01 2008

Rejected Out of Hand: FDA "Refuse-to-File" Letters Hit Five-Year High

Feb 01 2008

Related Companies

Merck KGaA

Theriva Biologics, Inc.

MiddleBrook Pharmaceuticals

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.